Abstract | BACKGROUND: Head and neck neoplasia is a major form of cancer in India, accounting for 30% of all cancers which occur in males and 11% of cancers which occur in females. Elevated serum L- fucose glycoprotein levels have been reported to be associated with neoplastic conditions involving various sites. Therefore, monitoring serum/tissue L- fucose glycoprotein levels could be a promising approach for the early diagnosis and prognosis of head neck cancers. AIM: This study was carried out to determine the significance of serum L- fucose levels in head and neck malignancies. SETTINGS AND DESIGN: This comparative study was carried out at a tertiary care hospital in South India. MATERIAL AND METHODS: Serum L- fucose glycoprotein levels were estimated in 50 patients with histopathologically confirmed head and neck malignancies and they were compared with those of 50 age- and sex-matched healthy controls. STATISTICAL ANALYSIS USED: Student's t-test was used to compare L- fucose glycoprotein levels in study and control groups. RESULTS: Most common site of the primary tumour in the current study was oral cavity, followed by larynx, hypopharynx and oropharynx respectively. Comparison of glycoprotein L- fucose in two groups showed more than a two-fold rise in serum fucose levels in cases as compared to the those in controls, with mean values of 11.33±7.39 and 4.74±1.55 mg% in cases and controls respectively. There was no relationship between serum fucose levels and age, sex and tumour differentiation. CONCLUSION: Serum glycoprotein L- fucose levels can be used as an effective biochemical indicator in conjunction with clinical diagnostic procedures in head and neck neoplasia and they may be useful for monitoring recurrences.
|
Authors | Rathan K S Shetty, Satheesh Kumar Bhandary, Arunava Kali |
Journal | Journal of clinical and diagnostic research : JCDR
(J Clin Diagn Res)
Vol. 7
Issue 12
Pg. 2818-20
(Dec 2013)
ISSN: 2249-782X [Print] India |
PMID | 24551646
(Publication Type: Journal Article)
|